Jeanine Peters‐Kennedy

Jeanine Peters‐Kennedy

Auto-generated profile, based on publicly available information

Jeanine Peters‐Kennedy

Department of Population Medicine and Diagnostic Sciences Cornell University, College of Veterinary Medicine Ithaca New York USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2022 in Veterinary Dermatology
Verified
Journal Article
Open access
MLMelissa Loewinger
Melissa Loewinger
JWJoseph J. Wakshlag
Joseph J. Wakshlag
DBDaniel Bowden
Daniel Bowden
JPJeanine Peters‐Kennedy
Jeanine Peters‐Kennedy
ARAndrew Rosenberg
Andrew Rosenberg
Background: Cannabidiol (CBD) and cannabidiolic acid (CBDA) are reported to have antinociceptive, immunomodulatory and anti‐inflammatory actions.Objectives: To determine if CBD/CBDA is an effective therapy for canine atopic dermatitis (cAD).Animals: Thirty‐two privately owned dogs with cAD.Materials and methods: Prospective, randomised, double‐blinded, placebo‐controlled study. Concurrent therapies were allowed if remained unchanged. Dogs were randomly assigned to receive either 2 mg/kg of an equal mix of CBD/CBDA (n = 17) or placebo for 4 weeks. On Day (D)0, D14 and D28, Canine Atopic Dermatitis Extent and Severity Index, 4th iteration (CADESI‐04) and pruritus Visual Analog Scale (pVAS) scores were determined by investigators and owners, respectively. Complete blood count, serum biochemistry profiles and cytokine bioassays were performed on serum collected on D0 and D28.Results: There was no significant difference in CADESI‐04 from D0 to D14 (p = 0.42) or D28 (p = 0.51) in either group. pVAS scores were significantly lower for the treatment group at D14 (p = 0.04) and D28 (p = 0.01) and a significant change in pVAS from baseline was seen at D14 (p = 0.04) and not D28 (p = 0.054) between groups. There was no significant difference in serum levels of interleukin (IL)‐6, IL‐8, monocyte chemoattractant protein ‐ 1, IL‐31 or IL‐34 between groups at D0 or D28. Elevated alkaline phosphatase was observed in four of 17 treatment group dogs.Conclusions and clinical relevance: CBD/CBDA as an adjunct therapy decreased pruritus, and not skin lesions associated with cAD in dogs.

1 December 2008 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
JPJeanine Peters-Kennedy
Jeanine Peters-Kennedy
DSDanny W. Scott
Danny W. Scott
WMWilliam H. Miller
William H. Miller
Imiquimod is a topical immune response modifier and stimulator used in humans to treat a number of cutaneous neoplasms. This case report describes a cat with actinic keratoses and squamous cell carcinoma of the pinnae. The pinnal lesions were treated with topical 5% imiquimod three times per week. Treatment was discontinued after 82 days of therapy. Twelve weeks of topical imiquimod application resulted in clinical resolution of the pinnal lesions. Although no post-treatment biopsies were performed, there was no relapse of the pinnal lesions in 5 months of clinical follow-up. Expected side effects were limited to erythema, crusting, alopecia, and mild discomfort at the sites of application during the first 3 weeks of application. These results suggest that topical imiquimod, although unproven, might be a therapeutic option or adjunct to therapy for cats with actinic keratoses and squamous cell carcinoma, especially those cats for whom surgery and radiation therapy are not an option.

19 November 2018 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
JPJ. Peters‐Kennedy
J. Peters‐Kennedy
CLC. E. Lange
C. E. Lange
SRS. L. Rine
S. L. Rine
RHR. P. Hackett
R. P. Hackett

1 October 2011 in American Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
JWJoseph Wakshlag
Joseph Wakshlag
JPJeanine Peters-Kennedy
Jeanine Peters-Kennedy
JBJennifer J. Bushey
Jennifer J. Bushey
JLJohn P Loftus
John P Loftus
Objective—To assess expression pattern and subcellular compartmentalization of 5-lipoxygenase in cutaneous, UV radiation–induced, and oral squamous cell carcinomas (SCCs) in cats and determine the effects of cyclooxygenase or 5-lipoxygenase inhibition on proliferation or apoptosis in a feline oral squamous cell carcinoma (SCCF1) cell line. Sample—60 archived paraffin-embedded samples of SCCs from 60 cats and SCCF1 cells. Procedures—Retrospective immunohistochemical analysis of the archived samples of SCCs (20 cutaneous, 20 UV radiation–induced, and 20 oral tumors) was performed. Cell culture proliferation assays involving SCCF1 cells were performed, and tepoxalin-induced apoptosis and signaling were examined via western blotting and annexin V staining. Results—Immunohistochemically, staining for 5-lipoxygenase was most frequently of greatest intensity in oral SCCs, whereas staining of cutaneous and UV radiation–induced lesions had less consistent 5-lipoxygenase expression. Exposure of SCCF1 cells to the 5-lipoxygenase inhibitor tepoxalin resulted in apoptosis; the effect appeared to be mediated via alteration of cell signaling rather than via suppression of lipid mediators that are typically produced as a result of 5-lipoxygenase activity. Conclusions and Clinical Relevance—In cats, expression of 5-lipoxygenase in SCCs appeared to differ depending on tumor location. The influence of tepoxalin-induced 5-lipoxygenase inhibition on a 5-lipoxygenase–expressing cell line coupled with the notable expression of 5-lipoxygenase in oral SCCs suggested that 5-lipoxygenase inhibition may have therapeutic benefits in affected cats. Although the safety of tepoxalin in cats has yet to be investigated, 5-lipoxygenase inhibitors should be evaluated for use as a potential treatment for SCCs in that species.

21 August 2018 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
MIMaria K. Ierace
Maria K. Ierace
MCMichael S. Canfield
Michael S. Canfield
JPJeanine Peters‐Kennedy
Jeanine Peters‐Kennedy
CKCurtis W. Kane
Curtis W. Kane

29 July 2023 in Veterinary Pathology
Verified
Journal Article
Closed access
TWThomas Westermann
Thomas Westermann
EDElena Alina Demeter
Elena Alina Demeter
DDDiego G. Diel
Diego G. Diel
RRRandall W. Renshaw
Randall W. Renshaw
MLMelissa A. Laverack
Melissa A. Laverack
JPJeanine Peters-Kennedy
Jeanine Peters-Kennedy
Granulomatous mural folliculitis (GMF) is an uncommon reaction pattern occasionally observed in nonadapted ruminant hosts infected with malignant catarrhal fever viruses. This report characterizes GMF and concurrent cutaneous lesions in 16 goats with crusting dermatitis using histochemistry including hematoxylin and eosin, periodic acid–Schiff, and Grocott’s methenamine silver, and immunohistochemistry for CD3, CD20, ionized calcium binding adaptor molecule 1, and cytokeratin AE1/3. Infiltrates in all 16 GMF cases consisted of macrophages and fewer T lymphocytes, and variably included eosinophils, multinucleated histiocytic giant cells, and/or neutrophils. Formalin-fixed paraffin-embedded skin and fresh skin samples from caprine GMF cases were tested using pan-herpesvirus nested conventional polymerase chain reaction (PCR) and partial sequencing, ovine herpesvirus-2 (OvHV-2) real-time PCR, and OvHV-2 colorimetric in situ hybridization (ISH). Five of 16 goats with GMF (31%) were PCR positive for malignant catarrhal fever viruses, including caprine herpesvirus 3 in 1 goat and OvHV-2 in 4 goats. Three goats also had positive intranuclear OvHV-2 hybridization signal in follicular keratinocytes, among other cell types, localized to areas of GMF. Herpesviruses were not detected in the formalin-fixed paraffin-embedded skin of 9 goats without GMF. This case series describes relatively frequent detections of malignant catarrhal fever viruses in the skin of goats with GMF, including the first report of caprine herpesvirus 3, and localizes OvHV-2 infected follicular keratinocytes within areas of GMF.